
India approves dengue vaccine QDENGA for 4-60 age group
The story in brief
India's National Medical Commission proposed withholding approvals for under-resourced medical colleges, while the country approved the dengue vaccine QDENGA for ages 4-60. Andhra Pradesh reported minimal COVID-19 cases, but Kerala faces a specialist doctor shortage and rising flu cases. Screen-time guidelines for children have evolved with new research, and access to gender-affirming healthcare remains contested in the U.S.